| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Neuropharmacology
and2 Department of Molecular Biology, The Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, California 92037
and3 Cancer and Infectious Disease Research, Upjohn Laboratories, Kalamazoo, Michigan, U.S.A.
Specific pathogen-free cats were infected with the Maryland strain of FIV (FIV-MD) for the purpose of assessing the effects of FIV infection on the central nervous system (CNS). Two separate studies were performed, involving a total of 13 infected cats and six age-matched, sham-inoculated controls. All animals infected with FIV-MD seroconverted by 8 weeks post-infection and virus was recovered from peripheral blood mononuclear cells of all infected cats. All of the infected animals had lower absolute CD4+ cell counts and decreased CD4+/CD8+ ratios. Virus was recovered from the cerebrospinal fluid (CSF) of certain infected individuals, and antiviral antibody and pleocytosis were evident in the CSF of the majority of infected cats. Additionally, virus was recovered from tissue explants from the cerebellum, midbrain and brainstem of one sacrificed FIV+ cat. Specific neurological changes included anisocoria, delayed righting reflex and delayed pupillary reflex, as well as delayed visual and auditory evoked potentials, and marked alterations in sleep patterns similar to those reported for human immunodeficiency virus (HIV)-positive individuals. Histological evaluation revealed the presence of perivascular cuffing and glial nodules in FIV-infected cats. These results indicate that FIV causes an acute neurological disease that closely resembles the early neurological effects of HIV infection in humans and should serve well as an animal model for lentivirus-induced CNS disease.
Received 24 September 1993;
accepted 13 December 1993.
This article has been cited by other articles:
|
|
 |
|
  S. Huitron-Resendiz, S. de Rozieres, M. Sanchez-Alavez, B. Buhler, Y.-C. Lin, D. L. Lerner, N. W. Henriksen, M. Burudi, H. S. Fox, B. E. Torbett, et al. Resolution and Prevention of Feline Immunodeficiency Virus-Induced Neurological Deficits by Treatment with the Protease Inhibitor TL-3 J. Virol., May 1, 2004; 78(9): 4525 - 4532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Patrick, J. B. Johnston, and C. Power Lentiviral Neuropathogenesis: Comparative Neuroinvasion, Neurotropism, Neurovirulence, and Host Neurosusceptibility J. Virol., July 17, 2002; 76(16): 7923 - 7931. [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Nesbit and S. A. Schwartz In Vitro and Animal Models of Human Immunodeficiency Virus Infection of the Central Nervous System Clin. Vaccine Immunol., May 1, 2002; 9(3): 515 - 524. [Full Text] [PDF]
|
|
|
|
|
|
J. B. Johnston, C. Silva, and C. Power Envelope Gene-Mediated Neurovirulence in Feline Immunodeficiency Virus Infection: Induction of Matrix Metalloproteinases and Neuronal Injury J. Virol., February 22, 2002; 76(6): 2622 - 2633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Johnston, Y. Jiang, G. van Marle, M. B. Mayne, W. Ni, J. Holden, J. C. McArthur, and C. Power Lentivirus Infection in the Brain Induces Matrix Metalloproteinase Expression: Role of Envelope Diversity J. Virol., August 15, 2000; 74(16): 7211 - 7220. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. F. W. Horn, S. Huitron-Resendiz, M. R. Weed, S. J. Henriksen, and H. S. Fox Early physiological abnormalities after simian immunodeficiency virus infection PNAS, December 8, 1998; 95(25): 15072 - 15077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Power, R. Buist, J. B. Johnston, M. R. Del Bigio, W. Ni, M. R. Dawood, and J. Peeling Neurovirulence in Feline Immunodeficiency Virus-Infected Neonatal Cats Is Viral Strain Specific and Dependent on Systemic Immune Suppression J. Virol., November 1, 1998; 72(11): 9109 - 9115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Yu, J. N. Billaud, and T. R. Phillips Effects of feline immunodeficiency virus on astrocyte glutamate uptake: Implications for lentivirus-induced central nervous system diseases PNAS, March 3, 1998; 95(5): 2624 - 2629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Smith, K. M. Remington, B. D. Preston, R. F. Schinazi, and T. W. North A Novel Point Mutation at Position 156 of Reverse Transcriptase from Feline Immunodeficiency Virus Confers Resistance to the Combination of (-)-beta -2',3'-Dideoxy-3'-Thiacytidine and 3'-Azido-3'-Deoxythymidine J. Virol., March 1, 1998; 72(3): 2335 - 2340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Prospero-Garcia, L. H. Gold, H. S. Fox, I. Polis, G. F. Koob, F. E. Bloom, and S. J. Henriksen Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys PNAS, November 26, 1996; 93(24): 14158 - 14163. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
